These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25836967)

  • 1. Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs).
    Burden N; Chapman K; Sewell F; Robinson V
    J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):198-208. PubMed ID: 25836967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Working in partnership to advance the 3Rs in toxicity testing.
    Holmes AM; Creton S; Chapman K
    Toxicology; 2010 Jan; 267(1-3):14-9. PubMed ID: 19903508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving quality of science through better animal welfare: the NC3Rs strategy.
    Prescott MJ; Lidster K
    Lab Anim (NY); 2017 Mar; 46(4):152-156. PubMed ID: 28328893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 3Rs in research: a contemporary approach to replacement, reduction and refinement.
    MacArthur Clark J
    Br J Nutr; 2018 Aug; 120(s1):S1-S7. PubMed ID: 29081302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the 3Rs to neuroscience research involving nonhuman primates.
    Lemon RN
    Drug Discov Today; 2018 Sep; 23(9):1574-1577. PubMed ID: 29733893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities for improving animal welfare in rodent models of epilepsy and seizures.
    Lidster K; Jefferys JG; Blümcke I; Crunelli V; Flecknell P; Frenguelli BG; Gray WP; Kaminski R; Pitkänen A; Ragan I; Shah M; Simonato M; Trevelyan A; Volk H; Walker M; Yates N; Prescott MJ
    J Neurosci Methods; 2016 Feb; 260():2-25. PubMed ID: 26376175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making progress and gaining momentum in global 3Rs efforts: how the European pharmaceutical industry is contributing.
    Fleetwood G; Chlebus M; Coenen J; Dudoignon N; Lecerf C; Maisonneuve C; Robinson S
    J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):192-7. PubMed ID: 25836966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities for Refinement of Non-Human Primate Vaccine Studies.
    Prescott MJ; Clark C; Dowling WE; Shurtleff AC
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33808708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal experimentation: implementation and application of the 3Rs.
    Lewis DI
    Emerg Top Life Sci; 2019 Nov; 3(6):675-679. PubMed ID: 32915219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Online resources for improving the care and use of non-human primates in research.
    Prescott MJ
    Primate Biol; 2016; 3():33-40. PubMed ID: 33778154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Brazilian legal framework on the scientific use of animals.
    Filipecki AT; Machado CJ; Valle S; Teixeira Mde O
    ILAR J; 2011; 52(1):E8-15. PubMed ID: 21447857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Researchers' attitudes to the 3Rs-An upturned hierarchy?
    Franco NH; Sandøe P; Olsson IAS
    PLoS One; 2018; 13(8):e0200895. PubMed ID: 30110335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement, reduction and refinement.
    Flecknell P
    ALTEX; 2002; 19(2):73-8. PubMed ID: 12098013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANIMAL WELFARE FROM MOUSE TO MOOSE--IMPLEMENTING THE PRINCIPLES OF THE 3RS IN WILDLIFE RESEARCH.
    Lindsjö J; Fahlman Å; Törnqvist E
    J Wildl Dis; 2016 Apr; 52(2 Suppl):S65-77. PubMed ID: 26845301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NC3Rs gateway: Accelerating scientific discoveries with new 3Rs models and technologies.
    Percie du Sert N; Robinson V
    F1000Res; 2018; 7():591. PubMed ID: 29862024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global pharmaceutical company initiative: an evidence-based approach to define the upper limit of body weight loss in short term toxicity studies.
    Chapman K; Sewell F; Allais L; Delongeas JL; Donald E; Festag M; Kervyn S; Ockert D; Nogues V; Palmer H; Popovic M; Roosen W; Schoenmakers A; Somers K; Stark C; Stei P; Robinson S
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):27-38. PubMed ID: 23602904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease.
    Graham ML; Prescott MJ
    Eur J Pharmacol; 2015 Jul; 759():19-29. PubMed ID: 25823812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal Research, the 3Rs, and the "Internet of Things": Opportunities and Oversight in International Pharmaceutical Development.
    Niemi SM; Davies GF
    ILAR J; 2016 Dec; 57(2):246-253. PubMed ID: 28053077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal welfare and the 3Rs in European biomedical research.
    Wells DJ
    Ann N Y Acad Sci; 2011 Dec; 1245():14-6. PubMed ID: 22211967
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.